GlassScriptPhysician profile
Pamila E Rogers
NPI 1457637514
$1,989.71
in general payments reported to CMS, 2019-2025
16 companies · $735 in 2025
The $735 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $225 · 2023: $235 · 2024: $795 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,764.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $225.11 | 2022-2023 | Jynarque |
| Inspire Medical Systems, INC. | $168.05 | 2025 | Inspire |
| Janssen Pharmaceuticals, INC | $150.00 | 2024 | Invega Trinza, Invega Sustenna |
| Hologic Sales and Service, LLC | $146.70 | 2025 | Aptima |
| Madrigal Pharmaceuticals | $142.72 | 2025 | Rezdiffra |
| Sanofi-Aventis U.S. LLC | $139.42 | 2025 | |
| Jazz Pharmaceuticals INC. | $137.66 | 2025 | |
| Alnylam Pharmaceuticals INC. | $127.88 | 2024 | Onpattro |
| Lundbeck LLC | $124.73 | 2022 | |
| Argenx US, INC. | $122.64 | 2024 | Vyvgart |
| Novo Nordisk INC | $121.84 | 2024 | |
| Amgen INC. | $121.58 | 2024 | Repatha |
| Glaxosmithkline, LLC. | $118.07 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $110.20 | 2023 | Andexxa |
| Solventum Corporation | $17.74 | 2024 | V.A.C.Instill, Prevena |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Oxygen Therapy INC. | $15.37 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamila Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.